Outcome Measures in Psoriasis and Psoriatic Arthritis Noori KimAlice B. Gottlieb Clinical Trial Design and Outcome Measures (H Bachelez, Section Editor) 27 June 2013 Pages: 159 - 163
Outcome Measures in Psoriatic Disease Lihi EderDafna D. Gladman Clinical Trial Design and Outcome Measures (H Bachelez, Section Editor) 29 June 2013 Pages: 164 - 171
Ingenol Mebutate for the Treatment of Actinic Keratosis Andrea HuiOrit Markowitz Dermatopharmacology and Therapeutic Development (J Zeichner, Section Editor) 26 July 2013 Pages: 172 - 176
Status Report on Oral Isotretinoin in the Management of Acne Vulgaris: Why All the Discussion about Drug Absorption and Relapse Rates? James Q. Del Rosso Dermatopharmacology and Therapeutic Development (J Zeichner, Section Editor) 03 July 2013 Pages: 177 - 180
Topical Hypochlorous Acid (HOCl) as a Potential Treatment of Pruritus Robert Y. PelgriftAdam J. Friedman Dermatopharmacology and Therapeutic Development (J Zeichner, Section Editor) 03 July 2013 Pages: 181 - 190
Naftifine HCl 2 % Cream for the Treatment of Tinea Pedis: A Review Andrew J. ThompsonStephen K. Tyring Dermatopharmacology and Therapeutic Development (J Zeichner, Section Editor) 26 June 2013 Pages: 191 - 193